DSpace at RU >

Search Results

Results 1-50 of 67.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2011	"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary	Mikhailidis, D.P.; Elisaf, M.; Rizzo, M.; Berneis, K.; Griffin, B.; Zambon, A.; Athyros, V.; Graaf, J. de; Marz, W.; Parhofer, K.G.; Rini, G.B.; Spinas, G.A.; Tomkin, G.H.; Tselepis, A.D.; Wierzbicki, A.S.; Winkler, K.; Florentin, M.; Liberopoulos, E.
	2011	"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses	Mikhailidis, D.P.; Elisaf, M.; Rizzo, M.; Berneis, K.; Griffin, B.; Zambon, A.; Athyros, V.; Graaf, J. de; Marz, W.; Parhofer, K.G.; Rini, G.B.; Spinas, G.A.; Tomkin, G.H.; Tselepis, A.D.; Wierzbicki, A.S.; Winkler, K.; Florentin, M.; Liberopoulos, E.
	2011	Should preclinical vascular abnormalities be measured in asymptomatic adults to improve cardiovascular risk stratification?	Graaf, J. de; Holewijn, S.; Stalenhoef, A.F.H.; Sniderman, A.D.
	2011	A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk	Sniderman, A.D.; Williams, K.; Contois, J.H.; Monroe, H.M.; McQueen, M.J.; Graaf, J. de; Furberg, C.D.
	2011	Depressive symptom clusters are differentially associated with atherosclerotic disease	Bus, B.A.A.; Marijnissen, R.M.; Holewijn, S.; Franke, B.; Purandare, N.; Graaf, J. de; Heijer, M. den; Buitelaar, J.K.; Oude Voshaar, R.C.
	2011	Depressive symptom clusters are differentially associated with general and visceral obesity	Marijnissen, R.M.; Bus, B.A.A.; Holewijn, S.; Franke, B.; Purandare, N.; Graaf, J. de; Heijer, M. den; Buitelaar, J.K.; Oude Voshaar, R.C.
	2011	Underestimation of Effect of Thyroid Function Parameters on Morbidity and Mortality due to Intra-Individual Variation.	Ven, A.C. van de; Netea-Maier, R.T.; Medici, M.; Sweep, F.C.; Ross, H.A.; Hofman, A.; Graaf, J. de; Kiemeney, L.A.L.M.; Hermus, A.R.M.M.; Peeters, R.P.; Visser, T.J.; Heijer, M. den
	2011	Application and validation of a diagnostic algorithm for the atherogenic apoB dyslipoproteinemias: ApoB dyslipoproteinemias in a Dutch population-based study	Holewijn, S.; Sniderman, A.D.; Heijer, M. den; Swinkels, D.W.; Stalenhoef, A.F.H.; Graaf, J. de
	2011	Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue	Koenen, T.B.; Stienstra, R.; Tits, L.J.H. van; Graaf, J. de; Stalenhoef, A.F.H.; Joosten, L.A.B.; Tack, C.J.J.; Netea, M.G.
	2011	ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)	Reiner, Z.; Catapano, A.L.; Backer, G. de; Graham, I.; Taskinen, M.R.; Wiklund, O.; Agewall, S.; Alegria, E.; Chapman, M.J.; Durrington, P.; Erdine, S.; Halcox, J.; Hobbs, R.; Kjekshus, J.; Filardi, P.P.; Riccardi, G.; Storey, R.F.; Wood, D.; Bax, J.; Vahanian, A.; Auricchio, A.; Baumgartner, H.; Ceconi, C.; Dean, V.; Deaton, C.; Fagard, R.; Filippatos, G.; Funck-Brentano, C.; Hasdai, D.; Hoes, A.; Kearney, P.; Knuuti, J.; Kolh, P.; McDonagh, T.; Moulin, C.; Poldermans, D.; Popescu, B.A.; Sechtem, U.; Sirnes, P.A.; Tendera, M.; Torbicki, A.; Vardas, P.; Widimsky, P.; Windecker, S.; Berkenboom, G.; Graaf, J. de; Descamps, O.; Gotcheva, N.; Griffith, K.; Guida, G.F.; Gulec, S.; Henkin, Y.; Huber, K.; Kesaniemi, Y.A.; Lekakis, J.; Manolis, A.J.; Marques-Vidal, P.; Masana, L.; McMurray, J.; Mendes, M.; Pagava, Z.; Pedersen, T.; Prescott, E.; Rato, Q.; Rosano, G.; Sans, S.; Stalenhoef, A.F.H.; Tokgozoglu, L.; Viigimaa, M.; Wittekoek, M.E.; Zamorano, J.L.
	2011	Abdominal aortic aneurysm is associated with a variant in low-density lipoprotein receptor-related protein 1	Bown, M.J.; Jones, G.T.; Harrison, S.C.; Wright, B.J.; Bumpstead, S.; Baas, A.F.; Gretarsdottir, S.; Badger, S.A.; Bradley, D.T.; Burnand, K.; Child, A.H.; Clough, R.E.; Cockerill, G.; Hafez, H.; Scott, D.J.; Futers, S.; Johnson, A.; Sohrabi, S.; Smith, A.; Thompson, M.M.; Bockxmeer, F.M. van; Waltham, M.; Matthiasson, S.E.; Thorleifsson, G.; Thorsteinsdottir, U.; Blankensteijn, J.D.; Teijink, J.A.; Wijmenga, C.; Graaf, J. de; Kiemeney, L.A.L.M.; Assimes, T.L.; McPherson, R.; Folkersen, L.; Franco-Cereceda, A.; Palmen, J.; Smith, A.J.; Sylvius, N.; Wild, J.B.; Refstrup, M.; Edkins, S.; Gwilliam, R.; Hunt, S.E.; Potter, S.; Lindholt, J.S.; Frikke-Schmidt, R.; Tybjaerg-Hansen, A.; Hughes, A.E.; Golledge, J.; Norman, P.E.; Rij, A. van; Powell, J.T.; Eriksson, P.; Stefansson, K.; Thompson, J.R.; Humphries, S.E.; Sayers, R.D.; Deloukas, P.; Samani, N.J.
	2011	The inflammasome and caspase-1 activation: a new mechanism underlying increased inflammatory activity in human visceral adipose tissue	Koenen, T.B.; Stienstra, R.; Tits, L.J. van; Joosten, L.A.B.; Velzen, J.F. van; Hijmans, A.G.M.; Pol, J.A.; Vliet, J.A. van der; Netea, M.G.; Tack, C.J.J.; Stalenhoef, A.F.H.; Graaf, J. de
	2010	Regulation of plasma LDL : the apoB paradigm	Sniderman, A.; Graaf, J. de; Couture, P.; Williams, K.; Kiss, R.; Watts, G.F.
	2010	The interaction between decomposition, net n and p mineralization and their mobilization to the surface water in fens	Geurts, J.J.M.; Smolders, A.J.P.; Banach, A.M.; Graaf, J. de; Roelofs, J.G.M.; Lamers, L.P.M.
	2010	Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.	Brouwers, M.C.; Graaf, J. de; Greevenbroek, M.M. van; Schaper, N.; Stehouwer, C.D.A.; Stalenhoef, A.F.H.
	2010	Non-HDL C equals apolipoprotein B: except when it does not!	Sniderman, A.; Williams, K.; Graaf, J. de
	2010	Regulation of plasma LDL: the apoB paradigm.	Sniderman, A.D.; Graaf, J. de; Couture, P.; Williams, K.; Kiss, R.S.; Watts, G.F.
	2010	Non-invasive measurements of atherosclerosis (NIMA): current evidence and future perspectives.	Holewijn, S.; Heijer, M. den; Stalenhoef, A.F.H.; Graaf, J. de
	2010	Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.	Himbergen, T. van; Otokozawa, S.; Matthan, N.R.; Schaefer, E.J.; Buchsbaum, A.; Ai, M.; Tits, L.J.H. van; Graaf, J. de; Stalenhoef, A.F.H.
	2010	Diagnosis and treatment of apolipoprotein B dyslipoproteinemias.	Sniderman, A.; Couture, P.; Graaf, J. de
	2010	Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk.	Holewijn, S.; Heijer, M. den; Swinkels, D.W.; Stalenhoef, A.F.H.; Graaf, J. de
	2010	Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm.	Gretarsdottir, S.; Baas, A.F.; Thorleifsson, G.; Holm, H.; Heijer, M. den; Vries, J.P. de; Kranendonk, S.E.; Zeebregts, C.J.A.; Sterkenburg, S.M. van; Geelkerken, R.H.; Rij, A.M. van; Williams, M.J.; Boll, A.P.M.; Kostic, J.; Jonasdottir, A.; Jonasdottir, A.; Walters, G.B.; Masson, G.; Sulem, P.; Saemundsdottir, J.; Mouy, M.; Magnusson, K.P.; Tromp, G.; Elmore, J.B.; Sakalihasan, N.; Limet, R.; Defraigne, J.O.; Ferrell, R.E.; Ronkainen, A.; Ruigrok, Y.M.; Wijmenga, C.; Grobbee, D.E.; Shah, S.H.; Granger, C.B.; Quyyumi, A.A.; Vaccarino, V.; Patel, R.; Zafari, A.M.; Levey, A.I.; Austin, H.; Girelli, D.; Pignatti, P.F.; Olivieri, O.; Martinelli, N.; Malerba, G.; Trabetti, E.; Becker, L.C.; Becker, D.M.; Reilly, M.P.; Rader, D.J.; Mueller, T.; Dieplinger, B.; Haltmayer, M.; Urbonavicius, S.; Lindblad, B.; Gottsäter, A.; Gaetani, E.; Pola, R.; Wells, P.; Rodger, M.; Forgie, M.; Langlois, N.; Corral, J.; Vicente, V.; Fontcuberta, J.; España, F.; Grarup, N.; Jørgensen, T.; Witte, D.R.; Hansen, T.; Pedersen, O.; Aben, K.K.H.; Graaf, J. de; Holewijn, S.; Folkersen, L.; Franco-Cereceda, A.; Eriksson, P.; Collier, D.A.; Stefansson, H.; Steinthorsdottir, V.; Rafnar, T.; Valdimarsson, E.M.; Magnadottir, H.B.; Sveinbjornsdottir, S.; Olafsson, I.; Magnusson, M.K.; Palmason, R.; Haraldsdottir, V.; Andersen, K.; Onundarson, P.T.; Thorgeirsson, G.; Kiemeney, L.A.L.M.; Powell, J.T.; Carey, D.J.; Kuivaniemi, H.; Lindholt, J.S.; Jones, G.T.; Blankensteijn, J.D.
	2010	Impact of waist circumference versus adiponectin level on subclinical atherosclerosis: a cross-sectional analysis in a sample from the general population.	Holewijn, S.; Heijer, M. den; Tits, L.J.H. van; Swinkels, D.W.; Stalenhoef, A.F.H.; Graaf, J. de
	2009	Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.	Himbergen, T. van; Otokozawa, S.; Matthan, N.R.; Schaefer, E.J.; Buchsbaum, A.; Ai, M.; Tits, L.J.H. van; Graaf, J. de; Stalenhoef, A.F.H.
	2009	Brachial artery diameter is related to cardiovascular risk factors and intima-media thickness.	Holewijn, S.; Heijer, M. den; Swinkels, D.W.; Stalenhoef, A.F.H.; Graaf, J. de
	2009	Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients.	Koenen, T.B.; Tack, C.J.J.; Kroese, J.M.; Hermus, A.R.M.M.; Sweep, C.G.J.; Laak, J.A.W.M. van der; Stalenhoef, A.F.H.; Graaf, J. de; Tits, L.J.H. van; Stienstra, R.
	2009	The metabolic syndrome and its traits as risk factors for subclinical atherosclerosis.	Holewijn, S.; Heijer, M. den; Swinkels, D.W.; Stalenhoef, A.F.H.; Graaf, J. de
	2009	Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis.	Popa, C.; Netea, M.G.; Graaf, J. de; Hoogen, F.H.J. van den; Radstake, T.R.D.J.; Toenhake-Dijkstra, H.I.; Riel, P.L.C.M. van; Meer, J.W.M. van der; Stalenhoef, A.F.H.; Barrera, P.
	2008	A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias.	Graaf, J. de; Couture, P.; Sniderman, A.
	2008	Paraoxonase (PON1) is associated with familial combined hyperlipidemia.	Himbergen, TM van; Tits, L.J.H. van; Avest, E. ter; Roest, M.; Voorbij, H.A.; Graaf, J. de; Stalenhoef, A.F.H.
	2008	Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL.	Stalenhoef, A.F.H.; Graaf, J. de
	2008	Adiponectin multimer distribution in patients with familial combined hyperlipidemia.	Koenen, T.B.; Tits, L.J.H. van; Holewijn, S.; Lemmers, H.L.M.; Heijer, M. den; Stalenhoef, A.F.H.; Graaf, J. de
	2008	Parabolic relationship between plasma triacylglycerols and LDL-cholesterol in familial combined hyperlipidaemia: the multiple-type hyperlipidaemia explained?	Brouwers, M.C.; Graaf, J. de; Greevenbroek, MM van; Georgieva, A.M.; Kallen, CJ van der; Avest, E. ter; Stehouwer, C.D.A.; Stalenhoef, A.F.H.; Bruin, T.W.A. de
	2007	What is the role of non-invasive measurements of atherosclerosis in individual cardiovascular risk prediction?	Avest, E. ter; Stalenhoef, A.F.H.; Graaf, J. de
	2007	Plasma annexin A5 level relates inversely to the severity of coronary stenosis.	Tits, L.J.H. van; Heerde, W.L. van; Vleuten, G.M. van der; Graaf, J. de; Grobbee, D.E.; Vijver, L.P. van de; Stalenhoef, A.F.H.; Princen, H.M.
	2007	The involvement of upstream stimulatory factor 1 in Dutch patients with familial combined hyperlipidemia.	Vleuten, G.M. van der; Isaacs, A.; Hijmans, A.G.M.; Duijn, C.M. van; Stalenhoef, A.F.H.; Graaf, J. de
	2007	High plasma level of remnant-like particles cholesterol in familial combined hyperlipidemia.	Graaf, J. de; Vleuten, G.M. van der; Avest, E. ter; Dallinga-Thie, G.M.; Stalenhoef, A.F.H.
	2007	Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.	Vleuten, G.M. van der; Isaacs, A.; Zeng, W.W.; Avest, E. ter; Talmud, P.J.; Dallinga-Thie, G.M.; Duijn, C.M. van; Stalenhoef, A.F.H.; Graaf, J. de
	2007	Pulse wave velocity in familial combined hyperlipidemia.	Avest, E. ter; Holewijn, S.; Bredie, S.J.H.; Tits, L.J.H. van; Stalenhoef, A.F.H.; Graaf, J. de
	2007	Non-transferrin-bound iron is associated with plasma level of soluble intercellular adhesion molecule-1 but not with in vivo low-density lipoprotein oxidation.	Tits, L.J.H. van; Jacobs, E.M.G.; Swinkels, D.W.; Lemmers, H.L.M.; Vleuten, G.M. van der; Graaf, J. de; Stalenhoef, A.F.H.
	2007	Endothelial function in familial combined hyperlipidaemia.	Avest, E. ter; Holewijn, S.; Tits, L.J.H. van; Wit, H.M. de; Stalenhoef, A.F.H.; Graaf, J. de
	2007	Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.	Avest, E. ter; Sniderman, A.D.; Bredie, S.J.H.; Wiegman, A.; Stalenhoef, A.F.H.; Graaf, J. de
	2006	Can we exclude the TXNIP gene as a candidate gene for familial combined hyperlipidemia?	Vleuten, G.M. van der; Hijmans, A.G.M.; Heil, S.G.; Blom, H.J.; Stalenhoef, A.F.H.; Graaf, J. de
	2006	The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia.	Vleuten, G.M. van der; Kluijtmans, L.A.J.; Hijmans, A.G.M.; Blom, H.J.; Stalenhoef, A.F.H.; Graaf, J. de
	2006	Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia.	Tits, L.J.H. van; Himbergen, T. van; Lemmers, H.L.M.; Graaf, J. de; Stalenhoef, A.F.H.
	2006	Serum non-transferrin-bound iron and low-density lipoprotein oxidation in heterozygous hemochromatosis.	Tits, L.J.H. van; Jacobs, E.M.G.; Swinkels, D.W.; Lemmers, H.L.M.; Vleuten, G.M. van der; Graaf, J. de; Stalenhoef, A.F.H.
	2006	A genome-wide linkage scan for homocysteine levels suggests three regions of interest.	Vermeulen, S.; Vleuten, G.M. van der; Graaf, J. de; Hermus, A.R.M.M.; Blom, H.J.; Stalenhoef, A.F.H.; Heijer, M. den
	2006	Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.	Ballantyne, C.M.; Carmena, R.; Castro Cabezas, M.; Chapman, M.J.; Couture, P.; Graaf, J. de; Durrington, P.N.; Faergeman, O.; Frohlich, J.; Furberg, C.D.; Gagne, C.; Haffner, S.M.; Humphries, S.E.; Jungner, I.; Krauss, R.M.; Kwiterovich, P.; Marcovina, S.M.; Packard, C.J.; Pearson, T.A.; Reddy, K.S.; Rosenson, R.; Sarrafzadegan, N.; Sniderman, A.D.; Stalenhoef, A.F.H.; Stein, E.; Talmud, P.J.; Tonkin, A.M.; Walldius, G.; Williams, K.M.
	2006	Effects of pioglitazone in familial combined hyperlipidaemia.	Abbink-Zandbergen, E.J.; Graaf, J. de; Haan, J.H.A. de; Heerschap, A.; Stalenhoef, A.F.H.; Tack, C.J.J.
	2005	Letter regarding article by Tsimikas et al, "high-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial".	Tits, L.J.H. van; Graaf, J. de; Stalenhoef, A.F.H.

1 2 next